Feldan Therapeutics

Feldan Therapeutics is a clinical-stage pharmaceutical company developing treatments based on intracellular delivery of therapeutics using its proprietary Shuttle peptide technology. Its lead candidate, FLD-103, targets basal cell carcinoma, and the company is also advancing a pulmonary program. This technology aims to provide non-surgical treatment options and address unmet needs in dermatological and respiratory diseases.

Buy Funded Startups lists

Funding Round:

Funding Amount:

Date: 16-Apr-2025

Investors: Zynext Ventures USA LLC

Markets: Pharmaceutical, Biotechnology

HQ: Québec, Quebec, Canada

Founded: 2007

Website: http://www.feldan.com/

LinkedIn: https://ca.linkedin.com/company/feldantherapeutics

Twitter: https://twitter.com/feldan_com

Instagram: